Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update | RIGL Stock News
I'm PortAI, I can summarize articles.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) will report its Q2 2025 financial results on August 5, 2025, after market close. A live conference call and webcast will follow at 4:30 p.m. ET to discuss the results and provide a business update. Participants can join by calling 877-407-3088 (domestic) or 201-389-0927 (international). The webcast will be available for replay for 90 days. Rigel focuses on developing therapies for hematologic disorders and cancer.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: StockTitan The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments